No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
19 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
116 (estimated)
Sponsor
Nunaps Inc · Industry
Who this trial is looking for
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
This study evaluates the efficacy of digital language rehabilitation using LEXURE for the treatment of post-stroke aphasia. Half of participants will receive structured language training using the LEXURE application, while the other half will receive workbook-based language training as an active comparator.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
1. Diagnosed with hemorrhagic or ischemic stroke
2. At least 3 months have elapsed since stroke onset
3. History of aphasia resulting from stroke
4. Aphasia Quotient (AQ) score between 26 and 90 (inclusive) on the Korean version of the Western Aphasia Battery (K-WAB) or the Para…
Inclusion Criteria:
1. Diagnosed with hemorrhagic or ischemic stroke
2. At least 3 months have elapsed since stroke onset
3. History of aphasia resulting from stroke
4. Aphasia Quotient (AQ) score between 26 and 90 (inclusive) on the Korean version of the Western Aphasia Battery (K-WAB) or the Paradise Korean version of the Western Aphasia Battery-Revised (PK-WAB-R)
5. Adults aged 19 years or older
6. Native Korean speakers
7. Able to use the investigational device or perform workbook-based training without difficulty
8. Willing to participate voluntarily and provide written informed consent
Exclusion Criteria:
1. Diagnosed with language impairment due to causes other than stroke (e.g., traumatic brain injury, brain tumor, or neurodegenerative disease)
2. History of language impairment due to developmental disorders
3. Currently receiving speech-language therapy or participating in another clinical trial related to language function
4. Currently receiving medication for severe psychiatric disorders (e.g., bipolar disorder, major depressive disorder, schizophrenia, alcohol dependence, or substance abuse)
5. Illiterate individuals
6. Individuals deemed unsuitable for participation in this study by the investigator
7. Severe cognitive impairment that would interfere with understanding or performing the study interventions
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.